Ihuman Accounts Payable from 2010 to 2025

IH Stock  USD 2.72  0.01  0.37%   
Ihuman's Accounts Payable is increasing with slightly volatile movements from year to year. Accounts Payable is predicted to flatten to about 22.3 M. Accounts Payable is the amount Ihuman Inc owes to suppliers or vendors for products or services received but not yet paid for. It represents Ihuman's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2019-12-31
Previous Quarter
19.9 M
Current Value
25.8 M
Quarterly Volatility
7.3 M
 
Covid
Check Ihuman financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ihuman's main balance sheet or income statement drivers, such as Tax Provision of 40 M, Depreciation And Amortization of 14.1 M or Interest Expense of 13.1 M, as well as many indicators such as Price To Sales Ratio of 1.31, Dividend Yield of 0.0117 or PTB Ratio of 1.2. Ihuman financial statements analysis is a perfect complement when working with Ihuman Valuation or Volatility modules.
  
Check out the analysis of Ihuman Correlation against competitors.

Latest Ihuman's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Ihuman Inc over the last few years. An accounting item on the balance sheet that represents Ihuman obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Ihuman Inc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Ihuman's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ihuman's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Ihuman Accounts Payable Regression Statistics

Arithmetic Mean17,171,395
Geometric Mean16,266,819
Coefficient Of Variation35.62
Mean Deviation5,400,743
Median13,134,000
Standard Deviation6,117,126
Sample Variance37.4T
Range20.2M
R-Value0.75
Mean Square Error17.7T
R-Squared0.56
Significance0.0009
Slope959,513
Total Sum of Squares561.3T

Ihuman Accounts Payable History

202522.3 M
202425.5 M
202322.1 M
202224.2 M
202130.5 M
202021.6 M
201910.3 M

About Ihuman Financial Statements

Investors use fundamental indicators, such as Ihuman's Accounts Payable, to determine how well the company is positioned to perform in the future. Although Ihuman's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Accounts Payable25.5 M22.3 M

Currently Active Assets on Macroaxis

Check out the analysis of Ihuman Correlation against competitors.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.53)
Earnings Share
0.27
Revenue Per Share
17.883
Quarterly Revenue Growth
(0.08)
Return On Assets
0.0348
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.